This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Textron (TXT) Q1 Earnings Beat Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Textron's (TXT) total Q1 revenues of $3,024 million miss the Zacks Consensus Estimate by 1.8%. However, the reported figure increases 0.8% year over year.
General Dynamics (GD) Q1 Earnings Beat, Revenues Rise Y/Y
by Zacks Equity Research
General Dynamics' (GD) first-quarter revenues of $9,881 million beat the Zacks Consensus Estimate of $9,322 million by 6%. Revenues also improve 5.2% from that reported in the year-ago quarter.
Boeing's (BA) Q1 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
Boeing's (BA) Q1 revenues of $17.92 billion surpass the Zacks Consensus Estimate by 3.3%. The top line also improves 28% year over year
Raytheon Technologies' (RTX) Q1 Earnings Beat, Sales Up Y/Y
by Zacks Equity Research
Raytheon Technologies' (RTX) Q1 sales of $17,214 million beat the Zacks Consensus Estimate by 2.1%. The figure also rises 9.5% from $15,716 million recorded in the year-ago quarter.
Hexcel (HXL) Q1 Earnings Beat Estimates, Sales Rise Y/Y
by Zacks Equity Research
Hexcel's (HXL) total Q1 sales of $458 million beat the Zacks Consensus Estimate by 6.8%. Also, the top line witnesses an improvement of 17.2% from the year-ago quarter.
Zacks Industry Outlook Highlights Lockheed Martin, Northrop Grumman and General Dynamics
by Zacks Equity Research
Lockheed Martin, Northrop Grumman and General Dynamics have been highlighted in this Industry Outlook article.
3 Aerospace-Defense Stocks to Watch on Bright Jet Deliveries View
by Aparajita Dutta
A solid jet deliveries outlook and defense budget proposal should benefit aerospace-defense stocks amid supply chain disruption. You may keep a watch on LMT, NOC and GD.
Don't Ignore the Relative Strength of These 2 Defense Stocks
by Derek Lewis
Targeting stocks displaying relative strength is a great way for investors to insert themselves in favorable trends where buyers are in control.
Marathon Petroleum and KeyCorp have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Marathon Petroleum and KeyCorp are part of the Zacks Bull and Bear of the Day article.
3 Buy-Ranked Stocks That Beat on Earnings This Week
by Sejuti Banerjea
UAL, LMT and OMC shares are headed higher after solid earnings announcements.
Company News for Apr 19, 2023
by Zacks Equity Research
Companies in The News Are: BAC,LMT,BK,JBHT
Lockheed Martin Corporation (LMT) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Lockheed (LMT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Lockheed's (LMT) Q1 Earnings Top Estimates, Sales Rise Y/Y
by Zacks Equity Research
Lockheed's (LMT) first-quarter 2023 net sales of $15.13 billion surpass the Zacks Consensus Estimate by 1.9%. The top line rises 1.1% from the year-ago quarter.
Compared to Estimates, Lockheed (LMT) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Lockheed (LMT) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Raytheon (RTX) Wins $14.4M Deal to Support Patriot Missile
by Zacks Equity Research
Raytheon (RTX) clinches a $14.4 million contract for the supply of Patriot missile parts.
Lockheed Martin (LMT) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Lockheed (LMT) delivered earnings and revenue surprises of 5.93% and 1.89%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights Eli Lilly, Thermo Fisher Scientific, Lockheed Martin, Boston Scientific and Canadian Pacific Railway
by Zacks Equity Research
Eli Lilly, Thermo Fisher Scientific, Lockheed Martin, Boston Scientific and Canadian Pacific Railway are part of the Zacks top Analyst Blog.
Lockheed (LMT) Wins Contract to Build SEWIP AN/SLQ-32(V)6 Systems
by Zacks Equity Research
Lockheed (LMT) to engage in full-rate production of SEWIP AN/SLQ-32(V)6 and AN/SLQ-32C(V)6 systems.
Top Analyst Reports for Eli Lilly, Thermo Fisher Scientific & Lockheed Martin
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Thermo Fisher Scientific Inc. (TMO) and Lockheed Martin Corporation (LMT).
Will Poor Sales Volume Hurt Lockheed's (LMT) Q1 Earnings?
by Zacks Equity Research
Lockheed Martin's (LMT) Q1 results likely to reflect the impact of lower sales volume from the majority of the company's segments, along with lower segment FAS/CAS operating profit
Lockheed (LMT) Secures $172M Deal to Support F-35 Jet Program
by Zacks Equity Research
Lockheed (LMT) to provide special test/tooling equipment for increasing Block 4 manufacturing capacity in support of the F-35 jet program.
Boeing (BA) Wins $1.2B Deal to Supply Missiles & Spare Parts
by Zacks Equity Research
Boeing (BA) will supply 400 RGM-84L-4 Harpoon Block II Update (HIIU) Grade B canister tactical missiles along with Harpoon Coastal Defense System (HCDS) spares.
Lockheed (LMT) Wins Deal to Support F-35 Jet Program for Israel
by Zacks Equity Research
Lockheed (LMT) to provide a depot maintenance activation plan for establishing the F-35 aircraft's initial depot capability.
Lockheed Martin (LMT) Stock Moves -1.79%: What You Should Know
by Zacks Equity Research
In the latest trading session, Lockheed Martin (LMT) closed at $487.84, marking a -1.79% move from the previous day.
Earnings Preview: Lockheed Martin (LMT) Q1 Earnings Expected to Decline
by Zacks Equity Research
Lockheed (LMT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.